Cullinan Oncology LLC (CGEM) Insider Trading
- $11,332,672.00
- $12,719,231.93
- May 23, 2023
- Ansbert Gadicke
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 23, 2023 | CEO | 707 | $9.15 | Sell | $6,469.05 | |
May 18, 2023 | Insider | 239 | $8.76 | Sell | $2,093.64 | |
May 18, 2023 | CFO | 399 | $8.76 | Sell | $3,495.24 | |
May 12, 2023 | Insider | 193 | $8.78 | Sell | $1,694.54 | |
May 12, 2023 | CFO | 347 | $8.78 | Sell | $3,046.66 | |
April 25, 2023 | CEO | 716 | $10.59 | Sell | $7,582.44 | |
April 18, 2023 | Insider | 392 | $10.71 | Sell | $4,198.32 | |
April 18, 2023 | CFO | 398 | $10.71 | Sell | $4,262.58 | |
April 12, 2023 | CFO | 318 | $10.22 | Sell | $3,249.96 | |
April 12, 2023 | Insider | 176 | $10.22 | Sell | $1,798.72 | |
March 23, 2023 | CEO | 706 | $10.51 | Sell | $7,420.06 | |
Nov. 25, 2022 | Insider | 4,000 | $13.30 | Sell | $53,200.00 | |
Sept. 27, 2022 | Insider | 4,000 | $12.40 | Sell | $49,600.00 | |
Aug. 4, 2022 | Major Shareholder | 25,989 | $14.31 | Sell | $371,902.59 | |
Aug. 2, 2022 | Major Shareholder | 4,792 | $14.10 | Sell | $67,567.20 | |
July 25, 2022 | Insider | 8,000 | $14.51 | Sell | $116,080.00 | |
July 18, 2022 | Insider | 5,042 | $15.06 | Sell | $75,932.52 | |
July 11, 2022 | Acting Chief Business Officer | 39,800 | $13.33 | Sell | $530,534.00 | |
June 23, 2022 | Major Shareholder | 29,631 | $13.00 | Sell | $385,203.00 | |
June 21, 2022 | Major Shareholder | 22,319 | $12.77 | Sell | $285,013.63 | |
June 6, 2022 | CEO | 8,090 | $12.40 | Buy | $100,316.00 | |
June 1, 2022 | Major Shareholder | 751,396 | $11.00 | Buy | $8,265,356.00 | |
May 16, 2022 | Major Shareholder | 35,158 | $11.23 | Sell | $394,824.34 | |
May 12, 2022 | Major Shareholder | 264,072 | $9.25 | Sell | $2,442,666.00 | |
April 1, 2022 | Major Shareholder | 276,000 | $10.75 | Buy | $2,967,000.00 | |
Oct. 18, 2021 | Insider | 4,000 | $21.42 | Sell | $85,680.00 | |
Oct. 15, 2021 | CFO | 8,000 | $25.00 | Sell | $200,000.00 | |
Oct. 15, 2021 | Insider | 19,574 | $25.00 | Sell | $489,350.00 | |
Oct. 7, 2021 | Insider | 1,079 | $25.00 | Sell | $26,975.00 | |
Sept. 20, 2021 | Insider | 4,000 | $24.51 | Sell | $98,040.00 | |
Sept. 15, 2021 | Director | 888 | $29.16 | Sell | $25,894.08 | |
Sept. 15, 2021 | Major Shareholder | 6,425 | $29.16 | Sell | $187,353.00 | |
Sept. 13, 2021 | Major Shareholder | 3,595 | $29.10 | Sell | $104,614.50 | |
Sept. 13, 2021 | Director | 497 | $29.10 | Sell | $14,462.70 | |
Sept. 9, 2021 | Director | 1,898 | $29.35 | Sell | $55,706.30 | |
Sept. 9, 2021 | Major Shareholder | 13,727 | $29.35 | Sell | $402,887.45 | |
Sept. 7, 2021 | Insider | 28,118 | $28.95 | Sell | $814,016.10 | |
Sept. 7, 2021 | Director | 3,465 | $29.04 | Sell | $100,623.60 | |
Sept. 7, 2021 | Major Shareholder | 25,067 | $29.04 | Sell | $727,945.68 | |
Sept. 3, 2021 | Major Shareholder | 12,731 | $29.60 | Sell | $376,837.60 | |
Sept. 3, 2021 | Director | 1,760 | $29.60 | Sell | $52,096.00 | |
Sept. 1, 2021 | Director | 790 | $29.47 | Sell | $23,281.30 | |
Sept. 1, 2021 | Major Shareholder | 5,714 | $29.47 | Sell | $168,391.58 | |
Aug. 30, 2021 | Major Shareholder | 31,001 | $29.30 | Sell | $908,329.30 | |
Aug. 30, 2021 | Director | 4,285 | $29.30 | Sell | $125,550.50 | |
Aug. 27, 2021 | Major Shareholder | 13,357 | $29.09 | Sell | $388,555.13 | |
Aug. 27, 2021 | Director | 1,846 | $29.09 | Sell | $53,700.14 | |
Aug. 25, 2021 | Director | 237 | $29.09 | Sell | $6,894.33 | |
Aug. 25, 2021 | Major Shareholder | 1,713 | $29.09 | Sell | $49,831.17 | |
Aug. 23, 2021 | Major Shareholder | 53,359 | $29.11 | Sell | $1,553,280.49 |
Insiders are both buying and selling Cullinan Oncology LLC stock.
The insider traders at Cullinan Oncology LLC are: Ansbert Gadicke, Oncology Impact Fund L.P. Ubs, Jennifer Michaelson, Jeffrey Trigilio, Vision Scs F2, Leigh Zawel, Nadim Ahmed, Bioscience I 2017 Ltd F2, Bvf Partners L P/Il, Savill Corrine, Corrine Savill, and Jeffrey Alan Jones
The most active insider trader at Cullinan Oncology LLC is Ansbert Gadicke with 11 trades.
Oncology Impact Fund L.P. Ubs has sold the most Cullinan Oncology LLC stock with a total value of $5,128,294.40.
Bvf Partners L P/Il has bought the most Cullinan Oncology LLC stock with a total value of $19,497,712.00.
The most recent insider trade for Cullinan Oncology LLC was on May 23, 2023.
The single biggest insider buy for Cullinan Oncology LLC was from Bvf Partners L P/Il with a total value of $8,265,356.00 on June 1, 2022.
The single biggest insider sell for Cullinan Oncology LLC was from Vision Scs F2 with a total value of $2,442,666.00 on May 12, 2022.